Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Movement Disorders Clinical Practice|March 27, 2024
Intense Imagery Movements May Lead to Maladaptive Daydreaming: A Case Series and Literature ReviewTammy Hedderly, Claire Eccles, Osman Malik, et al.Regulatory Toxicology and Pharmacology : RTP|August 23, 2011
Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: a cross-company reviewSusan S Sparrow, Sally Robinson, Sue Bolam, et al.Experimental Cell Research|March 4, 2014
Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironmentJong-Hyuk Kim, Aric M Frantz, Katie L Anderson, et al.Regulatory Toxicology and Pharmacology : RTP|April 23, 2013
A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studiesKathryn Chapman, Fiona Sewell, Linda Allais, et al.Regulatory Toxicology and Pharmacology : RTP|February 26, 2008
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug developmentSally Robinson, Jean-Luc Delongeas, Elizabeth Donald, et al.Plos One|May 17, 2023
The expendables: Bioarchaeological evidence for pauper apprentices in 19th century England and the health consequences of child labourRebecca L Gowland, Anwen C Caffell, Leslie Quade, et al.European Child & Adolescent Psychiatry|October 18, 2021
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessmentNatalia Szejko, Sally Robinson, Andreas Hartmann, et al.European Child & Adolescent Psychiatry|July 27, 2021
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventionsPer Andrén, Ewgeni Jakubovski, Tara L Murphy, et al.Regulatory Toxicology and Pharmacology : RTP|August 1, 2014
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trialsFiona Sewell, Kathryn Chapman, Paul Baldrick, et al.Pageof 7